2022 Annual Meeting Press Kit
The ACAAI Annual Scientific Meeting is your best resource for what’s happening in the world of allergies andAsthma is a chronic, inflammatory lung disease characterized by recurrent breathing problems. People with asthma have acute episodes where the air passages in their lungs get narrower, and breathing becomes more difficult. Sometimes episodes of asthma are triggered by allergens, although infection, exercise, cold air and other factors are also important triggers." rel="tooltip">asthma.
News Releases
Kathleen May Installed as ACAAI President| (en espanol)
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector| (en espanol)
New Study Identifies Sexual Activity as Asthma Trigger| (en espanol)
Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability| (en espanol)
Smartphones are Reservoirs of Allergens According to New Research| (en espanol)
Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine| (en espanol)
Lowest Pollen Counts Occur Between 4:00 a.m. and Noon| (en espanol)
CRISPR Treatment Slows Swelling in Hereditary Angioedema Patients| (en espanol)
More Information
Browse the program
Sessions by track
Media information
About ACAAI
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administerImmunotherapy is a form of preventive and anti-inflammatory treatment of allergy to substances such as pollens, house dust mites, fungi, and stinging insect venom. Immunotherapy involves giving gradually increasing doses of the substance, or allergen, to which the person is allergic. The incremental increases of the allergen cause the immune system to become less sensitive to the substance, perhaps by causing production of a particular "blocking" antibody, which reduces the symptoms of allergy when the substance is encountered in the future." rel="tooltip">immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visitAllergyandAsthmaRelief.org. Join us onFacebook,PinterestandTwitter.
